A Safety and Efficacy Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With DissolveAV

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

October 2, 2021

Study Completion Date

January 4, 2022

Conditions
Fistulas Arteriovenous
Interventions
DEVICE

Dissolve AVF

Subjects in the test group will be treated with peripheral scoring drug balloon.

DEVICE

Armada 35

Subjects in the test group will be treated with plain balloon catheter.

Trial Locations (10)

200000

ShuGuang Hospital affiliated to Shanghai University of Traditional Chinese, Shanghai

Unknown

Emergency general hospital, Beijing

Peking Union Medical College Hospital, Beijing

Tongren hospital, Capital medical university, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Huashan hospital affiliated to FuDan university, Shanghai

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai

Taiyuan Central Hospital, Taiyuan

Shaoyifu hospital, zhejiang medical universiyt, Hangzhou

The First Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

DK Medical Technology (Suzhou) Co., Ltd.

INDUSTRY

NCT04226599 - A Safety and Efficacy Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With DissolveAV | Biotech Hunter | Biotech Hunter